Australia markets closed

Innate Pharma S.A. (IPHYF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
2.5800+0.2395 (+10.23%)
At close: 03:59PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
43,653
49,580
12,110
56,155
Cost of revenue
-
-
-
3,042
Gross profit
-
-
-
53,791
Operating expenses
Research development
58,160
51,663
47,004
49,708
Selling general and administrative
11,477
14,473
15,991
12,691
Total operating expenses
68,971
66,005
59,937
55,076
Operating income or loss
-25,318
-16,425
-47,827
1,079
Interest expense
-4,912
288
312
341
Total other income/expenses net
-
-41,805
2,330
-2,131
Income before tax
-62,630
-57,972
-45,478
-829
Income tax expense
0
0
0
0
Income from continuing operations
-62,630
-57,972
-45,478
-829
Net income
-62,688
-58,103
-52,809
-63,984
Net income available to common shareholders
-62,688
-58,103
-52,809
-63,984
Basic EPS
-0.79
-0.73
-0.66
-0.81
Diluted EPS
-0.79
-0.73
-0.66
-0.81
Basic average shares
79,923
79,640
79,543
78,935
Diluted average shares
79,923
79,640
79,543
78,935